TOP TIERMARKET NEWSWIRE
News & sentiment

PROTAGONIST THERAPEU (PTGX) — News & AI sentiment

PROTAGONIST THERAPEU (PTGX) news roundup. 2 stories in the past week, 6 over 30 days. Average 30-day sentiment is 61.5/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 3 sales totalling $41.4M — net selling of $41.4M. US House Periodic Transaction Reports (90-day window): 0 purchases (~$0) and 1 sale (~$33K). Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
2
avg sentiment 58/100
30d stories
6
avg sentiment 61.5/100
Insider net (90d)
$41.4M
0 buys · 3 sells
Congress (90d)
-1
0 buys · 1 sells

PTGX news in the last 24 hours, 7 days, 30 days and 90 days

How much PTGX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowPTGX storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days258/100PTGX headlines →
Last 30 days661.5/100PTGX headlines →
Last 90 days4062.7/100PTGX headlines →

Latest stories on PTGX

1d ago
4d ago
Oct 21
Oct 12
Oct 12
Oct 12
Sep 9
Sep 8
Sep 8
Sep 8
Sep 6
Sep 4
Sep 2
BMO raises Protagonist Therapeutics price target on Mimrylo approval
Investing.com Analyst Ratings61 · neutralanalyst
Sep 1
H.C. Wainwright raises Protagonist stock price target on FDA approval
Investing.com Analyst Ratings67 · bullishanalyst
Sep 1
Sep 1
Sep 1
Aug 31
Aug 31
Protagonist Therapeutics stock rating maintained at Buy by Clear Street
Investing.com Analyst Ratings61 · neutralanalyst
Aug 31
Aug 31
Aug 31
Aug 31
Aug 31
Aug 30
Open PTGX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →